scispace - formally typeset
D

Dita Maixnerova

Researcher at Charles University in Prague

Publications -  37
Citations -  1592

Dita Maixnerova is an academic researcher from Charles University in Prague. The author has contributed to research in topics: Nephropathy & Renal function. The author has an hindex of 15, co-authored 32 publications receiving 1293 citations.

Papers
More filters
Journal ArticleDOI

Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens

Krzysztof Kiryluk, +91 more
- 01 Nov 2014 - 
TL;DR: A genome-wide association study of IgA nephropathy (IgAN), the most common form of glomerulonephritis, with discovery and follow-up in 20,612 individuals of European and East Asian ancestry is performed, suggesting a possible role for host–intestinal pathogen interactions in shaping the genetic landscape of IgAN.
Journal ArticleDOI

Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis

Krzysztof Kiryluk, +54 more
- 21 Jun 2012 - 
TL;DR: Variation at IgAN susceptibility loci correlates with differences in disease prevalence among world populations and inform genetic, biological, and epidemiological investigations of IgAN and permit cross-comparison with other complex traits that share genetic risk loci and geographic patterns with IgAN.

Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis

Krzysztof Kiryluk, +54 more
TL;DR: In this article, the authors localized five IgAN susceptibility loci on Chr.6p21 (HLA-DQB1/DRB1, PSMB9/TAP1, and DPA1/DPB2 loci), Chr.1q32 (CFHR3/R1 locus), and Chr.22q12 (HORMAD2 locus) and tested association of these loci in eight new independent cohorts of Asian, European, and African-American ancestry.
Journal ArticleDOI

A nationwide blood spot screening study for Fabry disease in the Czech Republic haemodialysis patient population

TL;DR: Blood spot screening (BSS) represents a promising screening tool that has proven to be convenient and effective in uncovering unrecognized FD patients among the chronic HD population in Czech Republic.
Journal ArticleDOI

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update

TL;DR: Long-term follow-up analyses of the VALIGA cohort showed that the independent relationship between kidney biopsy findings and the risk of progression towards kidney failure in IgAN remains unchanged across all age groups and decades after the renal biopsy.